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Abstract
Background: Despite guidelines and campaigns to change prescribing behavior, General Practitioners (GPs)
continue to overprescribe benzodiazepines (BZDs). New approaches to improve prescribing are needed. Using
behavior change techniques and tailoring interventions to user characteristics are vital to promote behavior
change. This study evaluated the impact of an e-module on factors known to determine BZD prescribing practice.
Methods: A tailored e-module that focuses on avoiding initial BZD prescriptions (and using psychological
interventions as an alternative) was developed and offered to GPs in vocational training. Three self-report
assessments took place: at baseline, immediately after the module (short term) and at least six months after
completion (long term). Assessed determinants include GPs’ attitudes concerning treatment options, perceptions of
the patient and self-efficacy beliefs. Readiness to adhere to prescribing guidelines was evaluated through assessing
motivation, self-efficacy and implementability of non-pharmacological interventions.
Changes in determinants were analyzed using the Wilcoxon signed-rank test. Changes in readiness to adhere to
guidelines was analyzed using the nonparametric McNemar Bowker test.
Results: A desirable, significant and durable impact on determinants of BZD prescribing was observed. GPs (n =
121) underwent desirable changes in their attitudes, perceptions and self-efficacy beliefs and these changes
remained significant months after the intervention. Barriers to using a non-pharmacological approach often cited in
literature remained absent and were not highlighted by the intervention. Furthermore a significant impact on GPs’
readiness to adhere to guidelines was observed. Participants reported change in their ability to cope with
psychosocial consultations and to have tried using non-pharmacological interventions.
Conclusions: Tailoring an e-intervention to target group (GPs) characteristics appears to be successful in promoting
behavioral change in GPs undertaking vocational training. Significant and lasting changes were observed in
determinants of prescribing BZDs. The e-intervention resulted in a positive impact on participants’ readiness to
adhere to BZD prescribing guidance and their coping with psychosocial consultations.
Investigating which mechanisms of change are responsible for the observed effectiveness could help to refine and
improve future interventions.
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Background
Benzodiazepines (BZDs) are one of the most commonly
used psychotropic drugs to treat conditions such as in-
somnia and anxiety in primary care. However, long-term
use is associated with considerable adverse effects in-
cluding memory disruption, increased risk of accidents
and falls, and dependence [1–4]. Despite guidance advo-
cating use of non-pharmacological, psychological treat-
ments first-line, and using BZD only short-term and if
needed, numerous studies have shown that BZDs are
overprescribed and chronic use is common [5–9].
Since General Practitioners (GPs) regard prescribing of
BZDs as one of the most complex, demanding and un-
comfortable tasks in their clinical work [10], it is confus-
ing that GPs continue to prescribe these drugs
frequently. Reviews identify a variety of reasons for in-
consistent BZD prescribing in primary care [11]. The
main concern for GPs is to help the patient: GPs try to
manage the tension between minimizing prescribing and
their responsibility to help ‘deserving’ patients [10, 12].
In this context it is important to stress that patients also
have an impact on GPs’ prescribing decisions [11–15].
Sirdifield et al. [11] developed an explanatory model of
processes underlying current prescribing practices of
BZDs in primary care. This model can be used to support
and evaluate interventions to improve adherence to BZD
prescribing guidance. The model emphasizes that pre-
scribing BZDs is a behavioral outcome, determined by
several factors. Interventions should not merely focus on
acquiring knowledge about BZDs or non-pharmacological
alternatives, but should also address other determinants
contributing to inconsistent prescribing practices. Thus,
training programs should also focus on ambivalent atti-
tudes and perceptions, as they are important determinants
of inconsistent prescribing strategies [16].
Most training programs for GPs have focused on helping
patients discontinue long-term BZD use [17, 18]. Studies
evaluating these interventions generally operationalize im-
provement in prescribing as lower overall rates of BZD
prescriptions.
Although the best way to avoid BZD dependence is by
not initiating these drugs [10], fewer interventions focus
on initial prescriptions. Evaluative studies are confronted
with the complex task of defining prescribing appropriate-
ness and what is meant by an improvement in prescribing
practice [18]. Using quantities of BZD prescriptions as an
outcome measure, is consequently problematic. Thinking
beyond quantification of prescribing and selecting
psychological determinants of prescribing as outcome
measures makes more sense within this context. Such
studies are scarce as an explanatory model of processes
underlying prescribing BZD has only recently been
developed.
Along similar lines, educational interventions typically
focus on acquiring knowledge about correct prescribing
[18] and are seldom attuned to the psychological dynam-
ics occurring within GPs. Using behavior change tech-
niques is vital however, when promoting behavior
change [19]. There is consequently a compelling case for
GP – attuned interventions which focus on avoiding ini-
tial BZD prescriptions and using psychological treat-
ments as an alternative.
This study evaluates the impact of an e-module on the
readiness of GPs in vocational training to adhere to BZD
prescribing guidance. The effectiveness of the e-module
is evaluated by its impact on psychological determinants
(attitudes, perceptions and self-efficacy beliefs). Further-
more, participants’ readiness to change prescribing prac-
tice (motivation, self-efficacy and implementability of
non-pharmacological interventions) is assessed.
Methods
Participants and process
During a period of 2.5 years (January 2012 – July 2014),
all Flemish GPs in vocational training had an opportunity
to participate in a free e-module about BZD prescribing.
GPs in vocational training are graduate medical doctors
that work full-time for two years as a GP trainee under
the supervision of an experienced GP. The e-module was
publicized on the website of the inter-university center for
Flemish GPs in vocational training. This center informs
young GPs monthly by email about new educational
programs. GPs in vocational training could volunteer to
participate by registering for the web-based module.
Participants who gave informed consent for participating
in the study were asked to complete a self-report assess-
ment when starting and when ending the e-learning mod-
ule. Six months after completion, participants received an
email invitation for completing a post-intervention ques-
tionnaire. Non-responders were sent several reminders.
Intervention
The intervention focuses on avoiding initial BZD
prescriptions and using psychological interventions as
an alternative (see Additional file 1, [20–24]). The inter-
vention was a web-based program, following the evolution
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of e-learning as a popular alternative to face-to-face learn-
ing, including in continuing medical education. The e-
module drew on the existing theory of Self-Determination
(SDT [25]), which provides both theoretical grounds and
practical guidelines to create motivating learning environ-
ments [26, 27]. According to SDT [25], the e-module
aimed to fulfil basic psychological needs for autonomy,
competence, and relatedness of participants. Furthermore,
the intervention attunes to psychological dynamics that
are known to determine GPs’ BZD prescribing practices
(see below).
Outcome measures
The intervention was evaluated considering its impact
on psychological determinants and readiness to adhere
to prescribing guidelines and therefore focusing beyond
simply quantifying prescriptions. Assessed psychological
determinants comprised GPs’ attitudes concerning treat-
ment options and GPs’ perceptions of the patient, as de-
scribed in the explanatory model of Sirdifield et al. [11].
This model emphasizes how prescribing BZDs is a
behavioral outcome determined by several factors (GPs’
attitudes towards interventions, GPs’ perception of the
patient, GPs’ sense of responsibility). Since all trainees
participated on a voluntary basis, the third determinant
of the explanatory model (sense of responsibility for
BZD prescribing practice) was not assessed. Based on
the findings that GPs appear to use BZDs to deal with
their feelings of helplessness and uncertainty concerning
both the doctor-patient relationship and non-drug alter-
natives for BZDs [10], items assessing GPs’ self-efficacy
beliefs (beliefs about capabilities, a psychological deter-
minant of behavioral intentions [28]) were added to the
self-report assessments.
Readiness to adhere to prescribing guidelines was eval-
uated through assessing motivation, self-efficacy and
implementability of non-pharmacological interventions.
Based on the transtheoretical model (TTM), a frequently
used biopsychosocial model to conceptualize the process
of intentional behavior change [29, 30], participants were
asked to declare whether they intended to make a
change, had actually made efforts to change their pre-
scribing practice and state self-efficacy beliefs concern-
ing their ability to change their prescribing practice.
To assess the implementability of alternative, non-
pharmacological treatment strategies, participants evaluated
non-pharmacological interventions on their meaningfulness
and practical usefulness and declared whether they actually
used the listed treatment strategies in their practice.
Assessments
Three self-report assessments took place: one pre-
intervention (baseline measurement) and two post-
intervention assessments, immediately after completing
the module (short-term impact) and months after com-
pletion (long-term impact). All three self-report assess-
ments comprised 10 items evaluating psychological
determinants of BZD overprescribing in primary care
(Table 1). Determinants were assessed using 10 items
rated agree/disagree on a 5-point Likert scale. Addition-
ally, items assessing participants’ readiness to adhere to
BZD prescribing guidelines (Table 2) were added to the
self-report assessments. At each self-report assessment,
participants were asked to make a selection of state-
ments that they agreed with, in order to determine
where they were situated on the continuum between
‘not prepared to prescribe less’ and ‘already prescribing
little sleep medication’.
‘Intention to make a change’ was assessed at baseline
and when completing the module (short-time impact).
Self-perceived ‘efforts to change’ were assessed at
baseline and months after completing the module
(long-term impact). Items assessing self-efficacy beliefs
concerning one’s ability to change were added at all
three assessments.
The two post-intervention assessments comprised
items assessing the implementability of six alternative
treatment strategies (Table 3). After completing the
module, participants evaluated these psychological inter-
ventions on their meaningfulness and practical useful-
ness using a 5-point Likert scale. Six months after
ending the module, the non-drug treatment strategies
were evaluated on their practical usefulness (again using
a 5-point Likert scale) where participants were asked
whether they ‘never’, ‘rarely’ or ‘frequently’ used the listed
treatment strategies in their practice. In the last
questionnaire – administered months after ending the
module - participants rated on a 5-point Likert scale
whether they felt the E-intervention had changed their
practice.
To consider validity, all items were submitted to an
interdisciplinary expert group (GPs, psychologists and a
sociologist).
Analysis
Effects of the intervention were identified by using the
assessments within a pretest-posttest study design.
Short-term effects were identified using the assessment
undertaken when participants completed the module as
posttest. The assessment that was sent at least six
months after completing the intervention was used as
posttest to identify long-term effects.
The impact of the intervention on psychological deter-
minants was analyzed using the Wilcoxon signed-rank
test as the nonparametric equivalent to the dependent t-
test. This test was used to identify differences on each
paired ordinal variable.
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Table 1 Impact on Psychological Determinants of BZD overprescribing (n = 121)
strongly disagree (%) disagree (%) neutral opinion (%) agree (%) strongly agree (%) Wilcoxon Z p value
GPs’ attitudes concerning treatment options
1. The advantages of sleep medication outweigh the disadvantages.
Baseline (%) 29.3 53.7 14.6 2.4 0
Short term (%) 52.8 36.6 4.1 3.3 3.3 −2.618 .009**
Long term (%) 55.3 34.2 6.1 1.8 2.6 −3.331 .001**
2. There are no non-drug alternatives for sleep problems that are as effective as drugs.
Baseline (%) 18.7 47.2 26.8 5.7 1.6
Short term (%) 38.2 47.2 10.6 3.3 0.8 −4.333 <.001*
Long term (%) 41.2 37.7 14.9 4.4 1.8 −3.346 .001**
3. I don’t have time to treat sleep problems using non-drug therapies
Baseline (%) 16.3 51.2 22.8 8.9 0.8
Short term (%) 14.6 21.5 25.2 8.9 0 −0.161 .872
Long term (%) 14 53.5 23.7 7.9 0.9 −0.235 .814
4. The non-medicational treatment of sleep problems is the business of other professionals
Baseline (%) 34.1 50.4 10.6 4.9 0
Short term (%) 32 48.4 13.9 5.7 0 −1.197 .231
Long term (%) 31.9 50 10.3 5.2 2.6 −0.997 .319
5. Non-drug treatment of sleep problems needs to be supported with medication.
Baseline (%) 26.8 53.7 17.1 0.8 1.6
Short term (%) 37.4 52 10.6 0 0 −2.906 .004**
Long term (%) 45.1 46.9 7.1 0.9 0 −4.145 <.001*
GPs’ perception of the patient
6. If I do not prescribe medication to a patient with sleep problems, (s)he is dissatisfied.
Baseline (%) 0.8 17.9 27.6 50.4 3.3
Short term (%) 4.9 35.8 33.3 24.4 1.6 −5.797 <.001*
Long term (%) 6 34.5 30.2 27.6 1.7 −4.782 <.001*
7. It is difficult for a GP to motivate a patient with sleep problems to choose a non-medicational treatment.
Baseline (%) 0.8 17.9 12.2 51.2 17.9
Short term (%) 3.3 26 22 42.3 6.5 −4.549 <.001*
Long term (%) 1.7 22.4 15.5 50 10.3 −1.908 0.056
GPs’ self-efficacy beliefs
8. When I am not prescribing medication for sleep problems I feel like I am not empathic
Baseline (%) 22 51.2 13.8 13 0
Short term (%) 33.3 50.4 10.6 5.7 0 −3.154 .002**
Long term (%) 39.7 41.4 14.7 4.3 0 −3528 <.001*
9. I have the expertise to use non-drug treatment for sleep problems.
Baseline (%) 22.8 33.3 23.6 18.7 1.6
Short term (%) 0 11.4 33.3 51.2 4.1 −7.217 <.001*
Long term (%) 0.9 7.9 32.5 54.4 4.4 −7.133 <.001*
10. I often feel overwhelmed when a patient presents with psychosocial problems
Baseline (%) 6.5 42.3 21.1 26.8 3.3
Short term (%) 10.6 44.7 23.6 20.3 0.8 −2.246 .025*
Long term (%) 20.7 44.8 22.4 8.6 3.4 −4.611 <.001*
Within the text, participants who “agree” and “strongly agree” are referred to as “agreeing”. In the same way, participants who reported to “strongly
disagree” or “disagree” are generally referred to as “disagreeing”
*p < 0.05 **p < 0.01
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Effects on readiness to adhere to guidelines was ana-
lyzed using the nonparametric McNemar Bowker test.
The McNemar test was used to identify differences on
paired proportions on each selected statement as a
dichotomous variable.
Results
Participants
During a period of two and a half academic years, 33%
(266/803) of the Flemish GPs in vocational training used
the E-module on a voluntary basis and completed a
baseline self-report assessment. Most of them (64%, 171/
266, i.e. 21% of 803 potential participants) also com-
pleted a self-report assessment when completing the E-
module. About 70% (120/171) reported having spent
more than 3 h on the E-module and 87% (149/171)
chose to spread the intervention in time (as suggested),
with a median of 25 days.
One hundred twenty-one GPs in vocational training
(45% of the initial 266 participants, i.e. 15% of the 803
potential participants) also completed the follow-up
assessment, with a median of seven months between this
assessment and the baseline assessment. Only partici-
pants who completed all three assessments were in-
cluded in this study.
76% of the study sample were female and most of the
participants were in their late twenties (proportions
which are similar to the general population of GPs in vo-
cational training in Flanders). Participants were working
in different regions and graduated from different Flem-
ish universities. Assessed base-line characteristics are re-
ported in the tables.
Impact on psychological determinants
The assessments showed a desirable, significant and dur-
able impact of the intervention for several determinants
of BZD prescribing (Table 1). First, the assessments
showed enduring changes in GPs’ attitudes concerning
treatment options: not only short-term (on completing
the module), but also in the longer term (at least six
months later), attitudes changed significantly. Partici-
pants disagreed more strongly with the statement that
the advantages of BZDs outweigh their disadvantages
and they judged more strongly that non-drug alterna-
tives are as effective as BZDs. Participants disagreed
more strongly that non-drug treatments need to be sup-
ported with medication. Neither the idea of lacking time
to use non-drug interventions nor perceiving them as
the business of other professionals appeared to be a bar-
rier for participants at the baseline assessment. Since no
significant impact on these items was observed on the
short term nor on the longer term, the E-module did
not highlight such barriers.
In addition, the intervention significantly influenced
the way GPs perceived sleepiness patients. When com-
pleting the module, but also months later, participants
were less convinced that it took a medical prescription
to satisfy a patient. Although participants agreed less
strongly that patients were difficult to motivate in choos-
ing a non-drug treatment when completing the interven-
tion, this effect did not show statistical significance in
the longer term (Z = −1.908, p = 0.056).
Further, significant and durable changes were
observed concerning the self-efficacy beliefs of GPs in
vocational training. Not only in the short term, but
also in the longer term (at least six months later),
participants reported a significantly stronger sense of
self-efficacy. Participants disagreed more strongly that
they had to show empathy by prescribing and felt
Table 2 Readiness to adhere to prescribing guidelines (n = 121)
selected by (%) Mc Nemar p value
Intention to change
I do not intend to prescribe less sleep medication.
Baseline 0.8
Short term 0 1
I intend to prescribe less sleep medication within the next
weeks (< one month).
Baseline 19.5
Short term 37.4 12.971 <.001**
Made efforts to change
I have tried in the past to prescribe less sleep medication
Baseline 23.6
Long term 67.2 41.397 <.001**
I have been trying to prescribe less sleep medication for some time
(more than 6 months).
Baseline 22.8
Long term 63.8 38.473 <.001**
Self-efficacy beliefs
I intend to prescribe less sleep medication* but don’t know how.
Baseline 43.1
Short term 2.4 42.875 <.001**
Long term 1.7 43.184 <.001**
I am trying at the moment to prescribe less sleep medication but
without success.
Baseline 29.3
Short term 12.2 13.793 <.001**
Long term 15.5 7.314. .007**
I am trying at the moment to prescribe less sleep medication and
have succeeded in doing so.
Baseline 12.2
Short term 47.2 34.588 <.001**
Long term 62.9 50.766 <.001**
*p < 0.05 ** p < 0.01
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more strongly that they had the expertise to use non-
pharmacological interventions. When starting the
module, 20.3% felt that they had such expertise, while
58.8% reported this months after ending the E-
module. Also, participants reported feeling less over-
whelmed when a patient presented with psychosocial
problems during a consultation. At baseline 30.1%
reported feeling overwhelmed, while only 12% re-
ported this in longer term.
Impact on readiness to adhere to prescribing guidelines
The module showed significant and desirable effects on
participants’ readiness to change prescribing behavior
(Tables 2 & 3). Firstly, the intervention appeared to have
Table 3 Implementability of 6 demonstrated alternative treatment strategies (n = 121)
Short term (when ending) Long term (months later)
Meaningful (%) Useful (%) Useful (%) Used (%)
ICE model of communication
strongly disagree / never 0 0 0 1.7
disagree 0 0 0
neutral. no opinion / rarely 3.3 11.4 9.3 16.0
agree 42.3 48.4 56.8
strongly agree / frequently 54.5 40.2 33.9 82.4
Sleep hygiene education
strongly disagree / never 0 0 0 8.5
disagree 0 0 0
neutral. no opinion / rarely 1.7 4.9 0.9 29.7
agree 25.6 25.4 35.3
strongly agree / frequently 72.7 69.7 63.8 61.9
Stress-vulnerability model
strongly disagree / never 0.8 0.8 0.9 29.6
disagree 2.5 5.7 4.3
neutral. no opinion / rarely 10.7 22.1 17.1 39.1
agree 45.5 31.1 38.5
strongly agree / frequently 40.5 40.2 39.3 31.3
Sleep wake diary
strongly disagree / never 0.8 0.8 1.7 32.2
disagree 0 1.6 6.0
neutral. no opinion / rarely 4.1 17.2 20.7 49.6
agree 43.1 42.6 50.0
strongly agree / frequently 52 37.7 21.6 18.3
Stimulus control therapy
strongly disagree / never 0 0 1.7 37
disagree 0.8 0.8 1.7
neutral. no opinion / rarely 9 13.8 33.9 42.9
agree 39.3 44.7 33.9
strongly agree / frequently 50.8 40.7 28.8 20.2
ABC model
strongly disagree / never 0 0.8 1.7 50.9
disagree 4.9 11.4 16.0
neutral. no opinion / rarely 13.8 28.5 29.4 41.4
agree 55.3 41.5 38.7
strongly agree / frequently 26 17.9 14.3 7.8
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a significant and positive effect on participants’ inten-
tions and efforts to change their prescribing practices.
On completing the module the number of participants
intending to prescribe fewer BZDs almost doubled. The
percentage of participants reporting trying (or to have
been trying for some time) to prescribe less sleep medi-
cation almost tripled on the longer term.
More relevant however, is the significant and enduring
impact on participants’ self-efficacy beliefs. There was an
enduring and remarkable decrease in participants
reporting not knowing how to meet their goal of pre-
scribing less BZDs. When starting the module 43.1% re-
ported not knowing how to prescribe less sleep
medication, compared to only 1.7% on the longer term.
Furthermore, analyses showed a significant effect on
the number of participants reporting success in minim-
izing BZD prescribing. When starting the module, only
12.2% reported success, while several months after com-
pleting the E-module, 62.9% reported successfully min-
imizing BZD prescribing.
Finally, months after the intervention 85.1% of the par-
ticipants stated that the module changed their prescrib-
ing practice and participants reported implementing
several demonstrated, non-pharmacological interven-
tions in their practice (Table 3).
In particular, the ‘ICE model of communication’
(82.4%) and the booklet on sleep hygiene education
(61.9%) were frequently used and unanimously consid-
ered useful by participants. Also the ‘stress-vulnerability
model’, ‘the sleep wake diary’ and the booklet on stimulus
control therapy were frequently implemented and con-
sidered practically useful by most participants. ‘The ABC
model’ was the non-drug intervention which was least
often implemented, but this was also used by almost half
the participants. Most respondents (53%) also consid-
ered ‘the ABC model’ practically useful, although opin-
ions were divided.
Discussion
Main findings
We were able to document a significant impact of an E-
intervention on determinants of BZD prescribing among
GPs in vocational training. Furthermore, a lasting impact
on participants’ psychological dynamics and their readi-
ness to adhere to prescribing guidelines was docu-
mented. This long-term impact is the more remarkable
since participants were practicing GPs, encountering
many situations in which they were confronted with the
tension between wanting to minimize BZD prescribing
and feeling a responsibility to help ‘deserving’ patients.
Moreover, participants reported experimenting with sev-
eral demonstrated, non-drug interventions within these
complex consultations.
Observed changes in participants’ attitudes and self-
efficacy beliefs remained while barriers often cited in the
literature [11] remained absent: lacking time for non-
drug interventions or perceiving these to be the task of
other professionals were not observed during the inter-
vention nor did they arise when participants tried non-
drug interventions in the period after the intervention.
Anticipating difficulties motivating patients to accept
non-drug treatment was a barrier that diminished in the
short term, but this effect was not enduring. Although
research shows that GPs’ perceptions about patients’ ex-
pectations concerning sleep problems tend to be as-
sumed rather than being the product of an actual
dialogue [31], the reemergence of this barrier might
point out a reality and not merely a perception. We con-
sider this observation an argument for choosing multi-
faceted interventions when aiming to improve prescrib-
ing and use of BZDs: targeting both prescribers and con-
sumers appears to be the most successful strategy [18].
Moreover, the participation rate in our study demon-
strates that many full time working GPs in vocational
training are motivated to participate in an e-intervention
to learn about BZD prescribing and manage psychosocial
consultations. They engaged in several hours of learning,
spread over several weeks during the intervention and
passed several assessments. This suggests a sense of re-
sponsibility for BZD prescribing practice and an appreci-
ation of the e-learning modality among these young GPs.
Strengths and limitations
Despite guidelines and several campaigns to change pre-
scribing behavior, BZDs continue to be overprescribed
and new approaches to improve BZD prescribing prac-
tice are needed. The intervention described is innovative
in several ways. Firstly, it is a web-based and GP-tailored
intervention that is attuned to GPs’ ambivalent attitudes,
perceptions, and self-efficacy beliefs. Also, the presented
intervention focuses on avoiding initial BZD prescrip-
tions and using psychological treatments as an alterna-
tive. It is promising that we were able to document a
significant and long-term impact of this e-intervention.
Secondly, it has been agreed that changing the behav-
ior of health professionals is challenging and literature
provides little information to guide the choice of inter-
ventions aimed at doing so. We demonstrate that a the-
oretical and psychological understanding of underlying
processes helps to guide the development of effective in-
terventions, as Michie et al. [19] argue. Interventions re-
quire more than good content: using behavior change
techniques and tailoring interventions to user character-
istics are vital to promote behavior change, including
within internet delivered interventions [32]. Understand-
ing the behavior of healthcare professionals allows inter-
ventions to be attuned to their psychological dynamics
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instead of being limited to simply transferring know-
ledge. However, interventions aimed at changing health
professionals’ behavior tend to be rather preachy. This is
ironic since it is well known that preachy approaches are
not very helpful for achieving behavioral change in
patients.
Thirdly, our study highlights e-learning can be used ef-
fectively to attune to GPs and modify their attitudes,
perceptions and self-efficacy beliefs.
Fourthly, we demonstrated educational interventions
targeting health professionals can be evaluated by select-
ing relevant psychological determinants as outcome
measures. Thinking beyond decreased BZD prescrip-
tions, we were able to document the effectiveness of the
intervention through durable changes in several psycho-
logical determinants of prescribing practice.
Voluntary participation suggests a sense of responsibil-
ity for BZD prescribing practice among our participants.
Also the absence of some negative attitudes concerning
non-drug interventions was remarkable. Whether these
features distinguish included participants from other
GPs in vocational training is unknown. Also, reasons for
dropping out of our study remain unknown. Thus a se-
lection bias must be taken into account, certainly since
participants’ motivation for engaging in this intervention
and several assessments, is probably linked to the ques-
tioned attitudes and barriers. However, a participation of
33%, puts this in perspective.
The effectiveness of similar interventions with experi-
enced GPs is unknown and there are several arguments to
study the effectiveness of this e-intervention with other
groups of GPs. Since educational interventions (targeting
GPs) that do not rely upon voluntary participation tend to
achieve a larger reduction in BZD prescribing [18], this
could guide further research. Investigating which mecha-
nisms of change (such as user characteristics) are respon-
sible for the observed effectiveness could help to refine
and improve future interventions.
We were not able to register the impact of the e-
intervention on rates of BZD prescribing. We were merely
able to document GP characteristics that are likely to lead
to better prescribing practices. Since people do not always
do what they want to do or think they do, there will al-
ways remain a gap between psychological determinants,
reported behavior and actual behavior. Nevertheless, when
aiming to bring about enduring behavior change, it is es-
sential to target mechanisms of change [32]. For example
in antibiotic prescribing, the effectiveness of similar theor-
etical based and GP-tailored interventions on actual pre-
scribing behavior has been documented [33].
Conclusion
In conclusion, this study documents a significant and
long-term impact of a theoretical based e-intervention
on determinants of BZD prescribing in GPs in vocational
training. Our GP-tailored intervention significantly
changed several relevant psychological determinants of
BZD prescribing and had an impact on participants’
readiness to adhere to prescribing guidelines. Significant
changes in attitudes and self-efficacy beliefs remained in
the long-term, while participants encountered many
situations in which they were confronted with the com-
plex task of managing psychosocial consultations and in
which they experimented with demonstrated non-drug
interventions.
Additional file
Additional file 1: e-intervention: prescribing BZDs. This additional file
contains more details about the e-intervention that focuses on avoiding
initial BZD prescriptions and using psychological interventions as an
alternative. (DOCX 22 kb)
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